Hainan Poly Pharm Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Min Hua Fan
Chief executive officer
CN¥769.8k
Total compensation
CEO salary percentage | n/a |
CEO tenure | 12.2yrs |
CEO ownership | 39.9% |
Management average tenure | no data |
Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 26% Dip In Price Shows Sentiment Is Matching Revenues
Dec 18Hainan Poly Pharm (SZSE:300630) Is Making Moderate Use Of Debt
Dec 02What Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 46% Share Price Gain Is Not Telling You
Oct 08Hainan Poly Pharm. Co., Ltd (SZSE:300630) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable
Aug 16It's Down 27% But Hainan Poly Pharm. Co., Ltd (SZSE:300630) Could Be Riskier Than It Looks
Apr 21A Piece Of The Puzzle Missing From Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 27% Share Price Climb
Mar 06CEO
Min Hua Fan (63 yo)
12.2yrs
Tenure
CN¥769,800
Compensation
Ms. Min Hua Fan is Chairman & General Manager of Hainan Poly Pharm. Co., Ltd from October 30, 2012.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & GM | 12.2yrs | CN¥769.80k | 39.92% CN¥ 1.2b | |
CFO, Deputy GM & Non-Independent Director | 3yrs | CN¥583.00k | 0.041% CN¥ 1.3m | |
Deputy GM | 12.2yrs | CN¥590.20k | 0.23% CN¥ 7.1m | |
Non-Independent Director | 9.5yrs | no data | no data | |
Non-Employee Supervisor | 12.2yrs | no data | no data | |
Employee Representative to the Supervisory Board | 12.2yrs | no data | 0.000020% CN¥ 610.9 | |
Independent Director | 3yrs | CN¥60.00k | 0.00049% CN¥ 15.0k | |
Chairman of Supervisory Board | 3yrs | no data | no data | |
Independent Director | 3yrs | CN¥60.00k | no data | |
Independent Director | 3yrs | CN¥60.00k | no data |
6.3yrs
Average Tenure
52.5yo
Average Age
Experienced Board: 300630's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/31 19:17 |
End of Day Share Price | 2024/12/31 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hainan Poly Pharm. Co., Ltd is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yue Gao | Changjiang Securities Co. LTD. |
Zhizhong Jing | China Merchants Securities Co. Ltd. |
Jiaxi Xu | Industrial Securities Co. Ltd. |